The end of compounded GLP-1 drugs leaves many patients in a ‘lose-lose’ position
(statnews.com)
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options.
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options.